Dermatology · Birmingham, AL
NPI
1932133659
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1927 1st Ave N Ste 200
Birmingham, AL, 35203
Phone (205) 933-0987
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
5,953 services
Medicare patients, 2024
1,055
Average age 75
Drug cost, 2024
$5.3M
3,346 prescriptions
Company payments, 2025
$127K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James Krell was code 17003 (destruction skin lesion), 2,039 times for 407 patients. In total James Krell billed 5,953 services in 88 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,039 | 407 | $4.42 | $9,018 |
| 99213 Office E&M - Established | Office | 922 | 742 | $53.68 | $49K |
| 17000 Destruction Skin Lesion | Office | 634 | 508 | $32.96 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 588 | 136 | $0.72 | $425 |
| 11102 Skin Biopsy | Office | 276 | 236 | $60.82 | $17K |
| 17110 Destruction Skin Lesion | Office | 222 | 197 | $70.85 | $16K |
| 99214 Office E&M - Established | Office | 147 | 118 | $74.98 | $11K |
| 99212 Office E&M - Established | Office | 127 | 121 | $37.18 | $4,722 |
| 96372 Injection Administration | Office | 95 | 88 | $9.85 | $935 |
| 99203 Office E&M - New | Office | 87 | 87 | $70.33 | $6,119 |
| 11103 Skin Biopsy | Office | 78 | 52 | $35.21 | $2,746 |
| 11900 Skin | Office | 75 | 63 | $26.33 | $1,975 |
| 12032 Wound Repair - All Levels | Office | 60 | 57 | $192.84 | $12K |
| 17262 Destruction Skin Lesion | Office | 53 | 38 | $102.41 | $5,428 |
| 11603 Skin Lesion Excision | Office | 49 | 44 | $100.85 | $4,942 |
By year: 2022 $434K for 8,105 services; 2023 $354K for 7,844 services; 2024 $215K for 5,953 services.
Medicare prescription drug claims, 2024
In 2024, the drug James Krell prescribed most often to Medicare patients was Betamethasone Dipropionate, with 270 prescriptions and refills. In total James Krell wrote 3,346 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 270 | 278 | 190 | $11K |
| Doxycycline Hyclate Generic | 260 | 312 | 112 | $7,000 |
| Clobetasol Propionate Generic | 185 | 189 | 126 | $9,674 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 166 | 166 | 158 | $485 |
| Tacrolimus Generic | 134 | 135 | 64 | $33K |
| Dutasteride Generic | 125 | 235 | 33 | $3,809 |
| Methotrexate Methotrexate Sodium | 122 | 147 | 24 | $3,095 |
| Dupixent Syringe Dupilumab | 111 | 118 | Under 11 | $434K |
| Dupixent Pen Dupilumab | 93 | 93 | 15 | $351K |
| Cephalexin Generic | 90 | 90 | 83 | $450 |
| Triamcinolone Acetonide Generic | 89 | 99 | 62 | $1,275 |
| Meloxicam Generic | 88 | 97 | 15 | $312 |
| Humira(Cf) Pen Adalimumab | 88 | 88 | Under 11 | $587K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 87 | 94 | Under 11 | $696K |
| Fluocinonide Generic | 85 | 93 | 63 | $4,067 |
Brand drugs: 716 claims; generic drugs: 2,630 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Krell $127K ($127K in general payments such as food, travel and fees) from 24 companies. The largest payer was Galderma Laboratories, L.P. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 39 | $31K |
| Abbvie Inc. ABBV | 39 | $20K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $18K |
| UCB, Inc. UCB.BR | 14 | $16K |
| Lilly USA, LLC LLY | 14 | $15K |
| Regeneron Healthcare Solutions, Inc. REGN | 18 | $12K |
| Janssen Biotech, Inc. JNJ | 12 | $9,136 |
| Pfizer Inc. PFE | 11 | $4,900 |
| Amgen Inc. AMGN | 5 | $1,675 |
| LEO Pharma Inc. | 13 | $190 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.